Authors:
Wong, BK
Defeo-Jones, D
Jones, RE
Garsky, VM
Feng, DM
Oliff, A
Chiba, M
Ellis, JD
Lin, JH
Citation: Bk. Wong et al., PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolites, DRUG META D, 29(3), 2001, pp. 313-318
Authors:
Garsky, VM
Lumma, PK
Feng, DM
Wai, J
Ramjit, HG
Sardana, MK
Oliff, A
Jones, RE
DeFeo-Jones, D
Freidinger, RM
Citation: Vm. Garsky et al., The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy, J MED CHEM, 44(24), 2001, pp. 4216-4224
Authors:
Shi, XP
Chen, E
Yin, KC
Na, S
Garsky, VM
Lai, MT
Li, YM
Platchek, M
Register, RB
Sardana, MK
Tang, MJ
Thiebeau, J
Wood, T
Shafer, JA
Gardell, SJ
Citation: Xp. Shi et al., The Pro domain of beta-secretase does not confer strict zymogen-like properties but does assist proper folding of the protease domain, J BIOL CHEM, 276(13), 2001, pp. 10366-10373
Authors:
DeFeo-Jones, D
Garsky, VM
Wong, BK
Feng, DM
Bolyar, T
Haskell, K
Kiefer, DM
Leander, K
McAvoy, E
Lumma, P
Wai, J
Senderak, ET
Motzel, SL
Keenan, K
Van Zwieten, M
Lin, JH
Freidinger, R
Huff, J
Oliff, A
Jones, RE
Citation: D. Defeo-jones et al., A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo, NAT MED, 6(11), 2000, pp. 1248-1252
Citation: Hg. Ramjit et al., The significance of monoisotopic and carbon-13 isobars for the identification of a 19-component dodecapeptide library by positive ion electrospray Fourier transform ion cyclotron resonance mass spectrometry, RAP C MASS, 14(15), 2000, pp. 1368-1376
Authors:
Bogusky, MJ
Culberson, JC
Pitzenberger, SM
Garsky, VM
Wallace, A
Pessi, A
Koblan, KS
Citation: Mj. Bogusky et al., Conformation of a novel tetrapeptide inhibitor NH2-D-Trp-D-Met-Phe(pCl)-Gla-NH2 bound to farnesyl-protein transferase, J PEPT RES, 54(1), 1999, pp. 66-73